Zacks Investment Research on MSN
Should you invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...
Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...
Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to ...
Forecasters anticipate exponential growth throughout the biotech industry over the coming decade, paving the way for a series of stock market opportunities for investors throughout this period. The ...
Innovation drives growth in the biotech and pharmaceutical space. According to The Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. biopharmaceutical sector directly supports ...
The global biotechnology industry’s technological advancements continue to spur breakthrough products in key sectors. In the medical/healthcare arena, drugs, other therapeutics, and medical devices ...
Biotech plant developers are pleased with a proposal from USDA's Animal and Plant Health Inspection Service to create five new regulatory exemptions for genetically modified plants The industry has ...
Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state’s life science and biotechnology research industry. After nearly ...
The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...
From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Philadelphia’s biotechnology industry is facing a wave of uncertainty, as several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results